8AUGUST - 2020As medical science advances at a dizzying rate, so does the technology we rely on to assure new treatments are as safe as they are innovative.From gene editing to RNA vaccines, the era of personalized medicine is upon us – and it is fiercely competitive. It suggests that the pharmaceutical industry is turning to specialist contract research organizations (CROs) to provide advanced analytical services, using state-of-the-art techniques such as high field nuclear magnetic resonance (NMR) spectroscopy and liquid chromatography – coupled with mass spectrometry By Franck A. Vendeix, PhD, Associate Director, Analytical Services, Scientifi c Expert Consultant for the Analytical Services Group at AMRIIN MY OPINIONHow Technology Can Provide a Safe Journey from Bench to Bedside
< Page 7 | Page 9 >